Levroxa 1000mg Tablet contains Levetiracetam 1000mg, an antiepileptic medication primarily indicated for the treatment of partial onset seizures, myoclonic seizures, and primary generalized tonic-clonic seizures in patients with epilepsy. Levetiracetam acts by modulating synaptic neurotransmitter release through binding to the synaptic vesicle protein SV2A, thereby stabilizing neuronal activity and reducing seizure frequency. This medication is often used as adjunctive therapy but may also be prescribed as monotherapy depending on clinical judgment. Levroxa is well-absorbed orally, with rapid onset of action and minimal hepatic metabolism, reducing the risk of drug interactions. It is generally well-tolerated; common adverse effects include somnolence, dizziness, headache, and fatigue, while serious side effects such as mood changes or hypersensitivity reactions are rare but warrant immediate medical attention. Dosage should be individualized based on patient response, renal function, and concomitant therapies. Caution is advised in patients with renal impairment, and dose adjustments may be necessary. Levroxa should be used under strict medical supervision with regular monitoring to optimize therapeutic outcomes and minimize adverse effects. It is contraindicated in patients with known hypersensitivity to Levetiracetam or any excipients contained in the formulation.